Pharmaceutical development

The main task of Pharmaceutical Development is to create the optimal form of administration for the drug, depending on the respective illness, its localisation and the respective skin condition.

Based on a long experience, Galenics develops and optimises classical formulations and modern drug carrier systems to safeguard the ideal release of the active ingredient and at the same time ideally adapt the preparation to the therapy requirements. In addition, patient acceptance, which is of great importance alongside the compatibility and safety of topical formulations, is given special consideration.

Galenic development is closely accompanied by the analytical development already supports the creation of the new product very early on and carries out quality-determining checks, depending on the project progress. In the further course of the pharmaceutical development, the spectrum of tests required by law is carried out on highly promising prototypes in order to obtain the official approvals for clinical tests and thus facilitate the tests for effectiveness and compatibility on the patient.

Genuair	®
GenuairŪ
Therepeutic efficacy favoured by a safe and easy to use administration

Genuair is a registered trademark of Almirall, S.A.. It is the proposed trademark for the MDPI and is pending regulatory approval.

Almirall Sofotec

Healthcare professionals
Healthcare professionals
Access for doctors and pharmacists

Healthcare professionals access

Dermatologist
Dermatologist search
Find dermatologists near you

Start dermatologist search

Encyclopaedia
Encyclopaedia
This comprehensive work includes the entire diagnosis and therapy of the specialist areas of dermatology

Open encyclopaedia